Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,382 public trials 1,306 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Holmium-166 Retrospective Collection of Real-World Data

NCT05111795

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • ASZ Aalst Aalst, Belgium
  • OLV Aalst Aalst, Belgium
  • CUB Hôpital Erasme Brussels, Belgium
  • Universitätsklinikum Carl Gustav Carus Dresden, Germany
View Trial Details
Completed

A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir

NCT04365933

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • ENYO PHARMA Investigative site HK01 Hong Kong
  • ENYO PHARMA Investigative site KR01 Busan, South Korea
  • ENYO PHARMA Investigative site TW03 Kaohsiung City, Taiwan
  • ENYO PHARMA Investigative site TW04 Kaohsiung City, Taiwan
View Trial Details
Completed

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

NCT01865812

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Scripps Clinic La Jolla, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University Medical Center Indianapolis, Indiana, United States
View Trial Details
Completed

A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

NCT03232593

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +27 more
Locations
  • Dongnam Inst.of Radiological & Medical Sciences Busan, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Inje university Haeundae Paik Hospital Busan, South Korea
  • Dong-A University Hospital Busan, South Korea
View all 56 locations
View Trial Details
Completed

Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma

NCT01988493

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • 307 Hosptial of PLA Beijing, Beijing Municipality, China
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • Fuzhou General Hospital of Nanjing Military Area Command of Chinese PLA Fuzhou, Fujian, China
  • Sun Yat-sen University, Cancer Center Guangzhou, Guangdong, China
View all 43 locations
View Trial Details

Related conditions